Insecticides (India) Limited has informed the Exchange regarding a press release dated August 13, 2025, titled "press release for Q1".
INSECTICID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Insecticides (India) Limited reported strong Q1 FY26 results with consolidated revenue rising 5% year-on-year to ₹691.13 crore. Profit After Tax surged 18% to ₹58.11 crore, while EBITDA grew 17% to ₹84.59 crore with margins expanding by 125 basis points to 12.2%. The company saw a 20% growth in its premium products portfolio in the B2C segment, supported by strong performance in products like Torry Super, Terrox, Green Expert, and Stroke. During the quarter, IIL launched three new products, including SPARCLE in collaboration with Corteva Agriscience and Altair (a patented herbicide from Nissan Chemical Corporation). The Dahej manufacturing facility received necessary approvals and is expected to contribute significantly to future growth.
This is a positive earnings announcement showing healthy topline growth coupled with strong margin expansion and robust profit growth, likely to be viewed favorably by investors. The premiumization strategy, new product launches, and operational ramp-up of the Dahej facility signal a positive growth trajectory going forward.